Dicerna Pharmaceuticals, Inc (DRNA) Covered Calls

You can sell covered calls on Dicerna Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DRNA (prices last updated Fri 4:16 PM ET):

Dicerna Pharmaceuticals, Inc (DRNA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.51 -0.23 8.45 11.40 395K - 0.7B
Covered Calls For Dicerna Pharmaceuticals, Inc (DRNA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 10 0.20 11.20 -10.7% -177.5%
Apr 18 10 0.45 10.95 -8.7% -56.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of rare, viral infectious, chronic liver, and cardiovascular diseases. Its development programs include DCR-PHXC for the treatment of primary hyperoxaluria; DCR-HBVS for the treatment of chronic hepatitis B virus infection; and DCR-PCSK9 to treat hypercholesterolemia. The company has a collaborative research and license agreement with Boehringer Ingelheim International GmbH; a research collaboration and license agreement with Kyowa Hakko Kirin Co., Ltd.; and a license agreement with City of Hope. Dicerna Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.